Detalls del projecte
| Estatus | Acabat |
|---|---|
| Data efectiva d'inici i finalització | 1/01/21 → 31/12/23 |
Finançament
- Instituto de Salud Carlos III (ISCIII): 123.420,00 €
Targeting the MNK/eIF4E axis in cancer: a rational approach to enhance tumor sensitivity to chemo- and immunotherapy.
- Ramon y Cajal Agüeras, Santiago Jose (Investigador/a principal)
- Castellvi Vives, Josep (Investigador/a)